German HTA Negative On Benefits Of First Ever Peanut Allergy Treatment
Executive Summary
The decision by IQWiG could have an impact on how Palforzia is priced if the findings are upheld.
You may also be interested in...
England’s NICE Okays First Ever Peanut Allergy Treatment Palforzia
Aimmune Therapeutics secures agreement with NHS for “step change” in treating peanut allergy.
Companies Need EU Funding To Cover ‘Enormous Expenditure’ Of Complying With Revised GMP Rules
Important updates to good manufacturing practice guidelines are likely to mean medicine shortages, warns a German pharmaceutical industry group.
IGBA Welcomes Mexican Membership
The IGBA has welcomed Mexican pharmaceutical industry association ANAFAM as an associate member.